[Congressional Record Volume 167, Number 20 (Wednesday, February 3, 2021)]
[Senate]
[Pages S355-S356]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 208. Mr. BURR (for himself, Mr. Scott, of South Carolina, and Mr. 
Crapo) submitted an amendment intended to be proposed by him to the 
concurrent resolution S. Con. Res. 5, setting forth the congressional 
budget for the United States Government for fiscal year 2021 and 
setting forth the appropriate budgetary levels for fiscal years 2022 
through 2030; which was ordered to lie on the table; as follows:

       At the end of title III, add the following:

[[Page S356]]

  


     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO 
                   SUPPORTING INNOVATION IN THE COVID-19 RESPONSE.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     advancing biomedical innovation to respond to the COVID-19 
     pandemic, which may include activities to accelerate research 
     and development by partnering with private entities or 
     academic institutions to develop medical countermeasures and 
     to support State public health responses to the pandemic, by 
     the amounts provided in such legislation for those purposes, 
     provided that such legislation would not increase the deficit 
     over either the period of the total of fiscal years 2021 
     through 2025 or the period of the total of fiscal years 2021 
     through 2030.
                                 ______